Solstice Commences Alpha IP Program at Strathy Gold Project, Abitibi Subprovince
VANCOUVER, British Columbia, Oct. 23, 2024 (GLOBE NEWSWIRE) — Solstice Gold Corp. (TSXV: SGC) (“Solstice”, “we”, “our” or the “Company”) […]
ScottsMiracle-Gro Announces Timing of Fourth Quarter 2024 Financial Results and Webcast
MARYSVILLE, Ohio, Oct. 23, 2024 (GLOBE NEWSWIRE) — The Scotts Miracle-Gro Company (NYSE: SMG), the world’s leading marketer of branded […]
Perspective Therapeutics Presents Updates at the 37th Annual Congress of the European Association of Nuclear Medicine
SEATTLE, Oct. 23, 2024 (GLOBE NEWSWIRE) — Perspective Therapeutics, Inc. (“Perspective” or the “Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical company that […]
Winnebago Industries Reports Fourth Quarter and Full Year Fiscal 2024 Results
— Full Year Operating Cash Flow of $143.9 Million Supports Company’s Strategic Growth Investments — — $106.8 Million Returned to […]
Stifel Reports Third Quarter 2024 Results
ST. LOUIS, Oct. 23, 2024 (GLOBE NEWSWIRE) — Stifel Financial Corp. (NYSE: SF) today reported net revenues of $1.2 billion […]
MAG Announces Third Quarter 2024 Production from Juanicipio
VANCOUVER, British Columbia, Oct. 23, 2024 (GLOBE NEWSWIRE) — MAG Silver Corp. (TSX / NYSE American: MAG) (“MAG” or “MAG […]
Nova Drills 29m @ 7.1 g/t Au from Surface at RPM in Advance of Resource Update
Anchorage, Alaska, Oct. 23, 2024 (GLOBE NEWSWIRE) — Nova Minerals Limited (“Nova” or the “Company”) (NASDAQ: NVA) (ASX: NVA) (FRA: […]
Teleflex launches next-generation Arrow™ VPS Rhythm™ DLX Device and NaviCurve™ Stylet in Canada
WAYNE, Pa., Oct. 23, 2024 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today […]
TransUnion Announces Third Quarter 2024 Results
Exceeded third quarter 2024 financial guidance for revenue and earnings Accelerated revenue growth to 12 percent, driven by U.S. Financial […]
Revolution Medicines Presents Updated Data from RMC-6236 Monotherapy Study in Patients with Advanced Pancreatic Ductal Adenocarcinoma
Encouraging progression-free survival and overall survival profile Safety findings consistent with previously reported data, no new safety signals observed Investor […]
